Zone 2 Cardio Versus VO2 Max: Sorting the Training Trend From the Evidence
VO2 max strongly predicts longevity, but the evidence that slow, low-intensity Zone 2 training is the best way to raise it is weaker than the trend suggests.
Jan 15, 2025

Search
60 stories for“evidence”
VO2 max strongly predicts longevity, but the evidence that slow, low-intensity Zone 2 training is the best way to raise it is weaker than the trend suggests.
Jan 15, 2025

Berberine lowers cholesterol and blood sugar in small trials, but comparing it to semaglutide misreads both the data and the biology.
Feb 14, 2024

New body composition data compares lean mass loss on tirzepatide and semaglutide. Here is what is measured, and what remains unclear.
Jun 15, 2026

The label is contested, the thresholds differ between guidelines, and most people who have it never progress. It is also the one point in this whole condition where a trial showed you can change the outcome by more than half.
Jul 10, 2026

Meta-analyses now put exercise's effect on depression in the same range as antidepressant trials, with real implications for regions like the Gulf.
Apr 14, 2026

Peptide is a chemical category, not a claim. The two versions most people actually buy are the ones with the least regulation and, oddly, the best safety record. Here is what the trials support and what physics gets in the way of.
Aug 20, 2026

Mail-in stool tests promise personalized nutrition insight, but the same sample sent to different labs can come back with conflicting advice.
Oct 3, 2025

Doctors and followers spent a year disagreeing about nizam al-tayyibat without ever contradicting each other, because they were not answering the same question.
Jul 24, 2026

Large trials with more than 30,000 participants found vitamin D pills do little for people who are not deficient, reshaping decades of assumptions.
Jan 20, 2026

On 23 and 24 July, an FDA advisory committee looked at seven peptides and recommended that pharmacies be allowed to compound several of them. The vote is not binding, and the evidence gap has not moved.
Aug 11, 2026

Insulin is a peptide. So is Ozempic. So is the unlabelled vial someone is selling on Telegram. The word describes a chemical class, not a level of evidence, and that gap is where the market lives.
Aug 11, 2026

Decades of trials back creatine for muscle and strength, and newer research is testing brain benefits, but the hype has outrun some of the data.
Aug 19, 2024

Updated traveler attention around Ebola-affected areas underscores a basic rule: monitor official advice, know the symptoms and seek help without stigmatizing whole countries.
Jul 24, 2026

Trials now show insufficient sleep impairs insulin sensitivity directly, independent of weight gain, reshaping how doctors talk about diabetes risk.
Nov 2, 2024

Over-the-counter glucose monitors reached healthy consumers in 2024, but research suggests their readings may not mean what wearers assume.
Jul 22, 2025

Fear, disrupted sleep, grief and irritability are common during conflict. Evidence-based support begins with safety and practical care, while recognizing when professional help is urgent.
Jul 25, 2026

Biohackers take metformin to slow aging, but the trial designed to actually prove that, TAME, still has not finished enrolling.
May 6, 2024
